Skip to main content
Premium Trial:

Request an Annual Quote

Analytik Jena Takes 20 Percent Stake in Westburg

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Analytik Jena has acquired 20 percent of the shares of its Dutch distribution partner, Westburg, for €150,000 ($215,272).

Based in Leusden, The Netherlands, Westburg specializes in molecular diagnostics sales and distribution. Its primary markets are the Benelux and Scandinavian countries.

"We want our market share in the life sciences in Europe [to] continue to expand and are looking for growth opportunities in targeted regions," Analytik Jena CEO Klaus Berka said in a statement.

Analytik Jena is based in Jena, Germany, and sells bioanalytical instruments and kits. It said that for the current financial year it expects revenues from its products sold by Westburg to be around €400,000.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.